On Thursday, Oppenheimer made an adjustment to its rating for WW Grainger (NYSE:GWW) stock, shifting from Outperform to Perform. The firm's rationale behind the downgrade is based on the belief that the company has now achieved appropriate market recognition for its robust assets, supply chain capabilities, data analytics, enhanced pricing algorithms, and demand generation strategies.
The analyst's projection for WW Grainger's 2025 earnings per share (EPS) is set at $43.00, marking an 11% increase. This forecast includes a 6% rise in core High-Touch Solutions (HTS) sales, which constitute 80% of GWW's sales and 90% of its EBIT.
The expectation also hinges on an assumption of 1-2% market growth. Furthermore, the analyst suggests that a stronger short cycle inflection could potentially boost HTS growth to around 8% by 2025, which would add approximately $1.10-1.40 to the EPS.
To reach a 10% upside, WW Grainger would need to maintain roughly a 28x multiple based on the pro forma 2025 EPS estimate of approximately $44.25. The analyst indicates that at this stage, the current valuation likely warrants a period of testing and consolidation.
The commentary concludes with a note of slight hesitation regarding the downgrade decision, acknowledging the company's potential for visible long-term compounding. However, the firm has decided that, for now, a Perform rating is more suitable given the current market circumstances and valuation levels.
In other recent news, WW Grainger has been under the analysts' lens, with BofA Securities initiating coverage with an Underperform rating, citing contracting margins and a slowdown in market share gains. On the contrary, Erste Group upgraded the stock to Buy, highlighting the company's strong profitability.
CFRA also shifted its position from Sell to Hold, reflecting a more favorable outlook for the company. Morgan Stanley (NYSE:MS) initiated coverage with an Equalweight rating, suggesting potential for gross margin improvement.
WW Grainger has reported a 3.1% increase in sales for the second quarter of 2024, with its High-Touch Solutions and Endless Assortment segments posting sales increases of 3.1% and 3.3%, respectively. The company also issued $500 million in senior notes due to mature in 2034 as part of its broader financial strategy.
The company has adjusted its full-year outlook, expecting total daily organic constant currency sales to grow between 4% and 6%, with reported sales anticipated to be between $17 billion and $17.3 billion, and an EPS range of $38 to $39.50. These are among the recent developments within the company.
InvestingPro Insights
The recent downgrade of WW Grainger (NYSE:GWW) by Oppenheimer aligns with several InvestingPro metrics and tips that provide additional context to the company's current market position. According to InvestingPro data, GWW's P/E ratio stands at 30.18, which supports Oppenheimer's view that the stock may be fully valued at present. This is further reinforced by an InvestingPro Tip indicating that GWW is "Trading at a high P/E ratio relative to near-term earnings growth," with a PEG ratio of 5.73.
Despite the downgrade, GWW's financial health appears robust. The company boasts a strong dividend history, with an InvestingPro Tip noting that it "Has raised its dividend for 31 consecutive years." This consistency in dividend growth, coupled with a current dividend yield of 0.74% and a dividend growth rate of 10.22% over the last twelve months, underscores the company's commitment to shareholder returns.
The stock's recent performance has been impressive, with a one-year price total return of 52.07% and a year-to-date return of 35.14%. These figures align with the InvestingPro Tip highlighting a "High return over the last year." However, investors should note that the stock is trading near its 52-week high, with a price at 99.76% of its 52-week high value, potentially supporting Oppenheimer's decision to downgrade the stock.
For investors seeking a more comprehensive analysis, InvestingPro offers 15 additional tips for GWW, providing a deeper understanding of the company's market position and financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.